Kawakami Y, Suemaru K, Kawasaki H, Gomita Y
Department of Hospital Pharmacy, Okayama University Medical School, Japan.
Nihon Shinkei Seishin Yakurigaku Zasshi. 1996 Aug;16(4):139-43.
Behavioral changes in locomotor activity and stereotyped behaviors induced by daily administration (for 7 days) of mazindol (5 and 10 mg/kg, po) were compared with those induced by methamphetamine (10 mg/kg) in rats. On day 1, mazindol increased locomotor activity, which was enhanced by daily administrations. Stereotyped behaviors were also induced by mazindol, which became more marked following daily administrations. Methamphetamine markedly increased stereotyped behavior rather than locomotor activity on day 1, and the effects were not enhanced by daily administrations. The increased locomotor activity and stereotyped behaviors caused by mazindol and methamphetamine were markedly reduced by the dopamine receptor antagonist pimozide (0.1-0.4 mg/kg, ip) in a dose-dependent manner. These results suggest that repeated mazindol administration enhances locomotor-stimulant and stereotypy-producing effects, which are mediated by the central dopaminergic system.
将大鼠每日给予(持续7天)吗茚酮(5和10毫克/千克,口服)诱导的运动活动和刻板行为的行为变化与给予甲基苯丙胺(10毫克/千克)诱导的行为变化进行比较。在第1天,吗茚酮增加了运动活动,每日给药可增强这种作用。吗茚酮也诱导了刻板行为,每日给药后这种行为变得更加明显。甲基苯丙胺在第1天显著增加了刻板行为而非运动活动,且每日给药并未增强其作用。多巴胺受体拮抗剂匹莫齐特(0.1 - 0.4毫克/千克,腹腔注射)以剂量依赖的方式显著降低了吗茚酮和甲基苯丙胺引起的运动活动增加和刻板行为。这些结果表明,重复给予吗茚酮可增强运动兴奋和刻板行为产生作用,这些作用由中枢多巴胺能系统介导。